These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 37745398)

  • 1.
    Hanlon KS; Cheng M; De La Cruz D; Patel N; Santoscoy MC; Gong Y; Ng C; Nguyen DM; Nammour J; Clark SW; Kozarsky K; Maguire CA
    bioRxiv; 2023 Sep; ():. PubMed ID: 37745398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo selection in non-human primates identifies AAV capsids for on-target CSF delivery to spinal cord.
    Hanlon KS; Cheng M; Ferrer RM; Ryu JR; Lee B; De La Cruz D; Patel N; Espinoza P; Santoscoy MC; Gong Y; Ng C; Nguyen DM; Nammour J; Clark SW; Heine VM; Sun W; Kozarsky K; Maguire CA
    Mol Ther; 2024 Aug; 32(8):2584-2603. PubMed ID: 38845196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The AAV9 Variant Capsid AAV-F Mediates Widespread Transgene Expression in Nonhuman Primate Spinal Cord After Intrathecal Administration.
    Beharry A; Gong Y; Kim JC; Hanlon KS; Nammour J; Hieber K; Eichler F; Cheng M; Stemmer-Rachamimov A; Stankovic KM; Welling DB; Ng C; Maguire CA
    Hum Gene Ther; 2022 Jan; 33(1-2):61-75. PubMed ID: 34128391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positron Emission Tomography Quantitative Assessment of Off-Target Whole-Body Biodistribution of I-124-Labeled Adeno-Associated Virus Capsids Administered to Cerebral Spinal Fluid.
    Rosenberg JB; Fung EK; Dyke JP; De BP; Lou H; Kelly JM; Reejhsinghani L; Ricart Arbona RJ; Sondhi D; Kaminsky SM; Cartier N; Hinderer C; Hordeaux J; Wilson JM; Ballon DJ; Crystal RG
    Hum Gene Ther; 2023 Nov; 34(21-22):1095-1106. PubMed ID: 37624734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative Whole-Body Imaging of I-124-Labeled Adeno-Associated Viral Vector Biodistribution in Nonhuman Primates.
    Ballon DJ; Rosenberg JB; Fung EK; Nikolopoulou A; Kothari P; De BP; He B; Chen A; Heier LA; Sondhi D; Kaminsky SM; Mozley PD; Babich JW; Crystal RG
    Hum Gene Ther; 2020 Dec; 31(23-24):1237-1259. PubMed ID: 33233962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe Toxicity in Nonhuman Primates and Piglets Following High-Dose Intravenous Administration of an Adeno-Associated Virus Vector Expressing Human SMN.
    Hinderer C; Katz N; Buza EL; Dyer C; Goode T; Bell P; Richman LK; Wilson JM
    Hum Gene Ther; 2018 Mar; 29(3):285-298. PubMed ID: 29378426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Global CNS gene delivery and evasion of anti-AAV-neutralizing antibodies by intrathecal AAV administration in non-human primates.
    Gray SJ; Nagabhushan Kalburgi S; McCown TJ; Jude Samulski R
    Gene Ther; 2013 Apr; 20(4):450-9. PubMed ID: 23303281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selection of an Efficient AAV Vector for Robust CNS Transgene Expression.
    Hanlon KS; Meltzer JC; Buzhdygan T; Cheng MJ; Sena-Esteves M; Bennett RE; Sullivan TP; Razmpour R; Gong Y; Ng C; Nammour J; Maiz D; Dujardin S; Ramirez SH; Hudry E; Maguire CA
    Mol Ther Methods Clin Dev; 2019 Dec; 15():320-332. PubMed ID: 31788496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel random peptide libraries displayed on AAV serotype 9 for selection of endothelial cell-directed gene transfer vectors.
    Varadi K; Michelfelder S; Korff T; Hecker M; Trepel M; Katus HA; Kleinschmidt JA; Müller OJ
    Gene Ther; 2012 Aug; 19(8):800-9. PubMed ID: 21956692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intra-CSF AAV9 and AAVrh10 Administration in Nonhuman Primates: Promising Routes and Vectors for Which Neurological Diseases?
    Bey K; Deniaud J; Dubreil L; Joussemet B; Cristini J; Ciron C; Hordeaux J; Le Boulc'h M; Marche K; Maquigneau M; Guilbaud M; Moreau R; Larcher T; Deschamps JY; Fusellier M; Blouin V; Sevin C; Cartier N; Adjali O; Aubourg P; Moullier P; Colle MA
    Mol Ther Methods Clin Dev; 2020 Jun; 17():771-784. PubMed ID: 32355866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multiplexed barcode approach to simultaneously evaluate gene delivery by adeno-associated virus capsid variants in nonhuman primates.
    Stone D; Meumann N; Kuhlmann AS; Peterson CW; Xie H; Roychoudhury P; Loprieno MA; Vu XK; Strongin DE; Kenkel EJ; Haick A; Stensland L; Obenza WM; Parrott J; Nelson V; Murnane RD; Huang ML; Aubert M; Kiem HP; Büning H; Jerome KR
    Hepatol Commun; 2023 Feb; 7(2):e0009. PubMed ID: 37074875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AAV-PHP.B Administration Results in a Differential Pattern of CNS Biodistribution in Non-human Primates Compared with Mice.
    Liguore WA; Domire JS; Button D; Wang Y; Dufour BD; Srinivasan S; McBride JL
    Mol Ther; 2019 Nov; 27(11):2018-2037. PubMed ID: 31420242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Rationally Engineered Capsid Variant of AAV9 for Systemic CNS-Directed and Peripheral Tissue-Detargeted Gene Delivery in Neonates.
    Wang D; Li S; Gessler DJ; Xie J; Zhong L; Li J; Tran K; Van Vliet K; Ren L; Su Q; He R; Goetzmann JE; Flotte TR; Agbandje-McKenna M; Gao G
    Mol Ther Methods Clin Dev; 2018 Jun; 9():234-246. PubMed ID: 29766031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid evolution of blood-brain-barrier-penetrating AAV capsids by RNA-driven biopanning.
    Nonnenmacher M; Wang W; Child MA; Ren XQ; Huang C; Ren AZ; Tocci J; Chen Q; Bittner K; Tyson K; Pande N; Chung CH; Paul SM; Hou J
    Mol Ther Methods Clin Dev; 2021 Mar; 20():366-378. PubMed ID: 33553485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A strategy for high antibody expression with low anti-drug antibodies using AAV9 vectors.
    Davis-Gardner ME; Weber JA; Xie J; Pekrun K; Alexander EA; Weisgrau KL; Furlott JR; Rakasz EG; Kay MA; Gao G; Farzan M; Gardner MR
    Front Immunol; 2023; 14():1105617. PubMed ID: 37153616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of high-dose intracisterna magna and lumbar puncture intrathecal delivery of AAV9 in mice to treat neuropathies.
    Bailey RM; Rozenberg A; Gray SJ
    Brain Res; 2020 Jul; 1739():146832. PubMed ID: 32289279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comprehensive study of a 29-capsid AAV library in a non-human primate central nervous system.
    Kondratov O; Kondratova L; Mandel RJ; Coleman K; Savage MA; Gray-Edwards HL; Ness TJ; Rodriguez-Lebron E; Bell RD; Rabinowitz J; Gamlin PD; Zolotukhin S
    Mol Ther; 2021 Sep; 29(9):2806-2820. PubMed ID: 34298128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PET imaging of focused-ultrasound enhanced delivery of AAVs into the murine brain.
    Ajenjo J; Seo JW; Foiret J; Wu B; Raie MN; Wang J; Fite BZ; Zhang N; Malek R; Beinat C; Malik N; Anders DA; Ferrara KW
    Theranostics; 2023; 13(15):5151-5169. PubMed ID: 37908737
    [No Abstract]   [Full Text] [Related]  

  • 19. Application of polyploid adeno-associated virus vectors for transduction enhancement and neutralizing antibody evasion.
    Chai Z; Sun J; Rigsbee KM; Wang M; Samulski RJ; Li C
    J Control Release; 2017 Sep; 262():348-356. PubMed ID: 28789965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AAV Vectors Pseudotyped with Capsids from Porcine and Bovine Species Mediate In Vitro and In Vivo Gene Delivery.
    Yu DL; van Lieshout LP; Stevens BAY; Near KJJ; Stodola JK; Stinson KJ; Slavic D; Wootton SK
    Viruses; 2023 Dec; 16(1):. PubMed ID: 38257756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.